Changes in hepatic lipogenic and oxidative enzymes and glucose homeostasis induced by an acetyl-l-carnitine and nicotinamide treatment in dyslipidaemic insulin-resistant rats

Clinical and Experimental Pharmacology and Physiology

Volumn 40, Issue 3, 2013, Pages 205-211

  Ferreira, Maria R ^a   Camberos, Maria del C ^b   Selenscig, Dante ^a   Martucci, Lucía C ^b   Chicco, Adriana ^a   Lombardo, Yolanda ^a   Cresto, Juan C ^b  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Acetyl l carnitine; Dyslipidaemia; Glucose homeostasis; Insulin resistance; Lipogenesis inhibition; Nicotinamide; Sucrose rich diet

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID; FATTY ACID SYNTHASE; GLUCOSE; INSULIN; LEVACECARNINE; NEUREX; NICOTINAMIDE; OXIDOREDUCTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULINEMIA; INTRAABDOMINAL FAT; LIPID LIVER LEVEL; LIPOGENESIS; LIVER WEIGHT; MALE; NONHUMAN; RAT; RETROPERITONEAL FAT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ACETYL-COA CARBOXYLASE; ACETYLCARNITINE; ANIMALS; BODY WEIGHT; CARNITINE O-PALMITOYLTRANSFERASE; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DYSLIPIDEMIAS; ENERGY INTAKE; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; LIPOGENESIS; LIVER; MALE; NIACINAMIDE; OXIDATIVE STRESS; PANCREAS; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 84874326009     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12050     Document Type: Article

References (36)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.
3. Kraegen EW, Cooney GJ. The role of free fatty acids in muscle insulin resistance. In: Marshall SM, Home PD, Rizza RA (eds). The Diabetes Annual/12. Elsevier Science BV, Amsterdam, 1999; pp. 141-50.
4. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 2002; 23: 201-29.
5. Hegarty BD, Furler SM, Ye J, Cooney GJ, Kraegen EW. The role of intramuscular lipid in insulin resistance. Acta Physiol. Scand. 2003; 178: 373-83.
6. Petersen KF, Befroy D, Dufour S et al. Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 2003; 300: 1140-2.
7. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51: 2944-50.
8. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 2004; 350: 664-71.
9. Mingrone G. Carnitine in type 2 diabetes. Ann. N.Y. Acad. Sci. 2004; 1033: 99-107.
10. Giancaterini AGA, De Gaetano A, Mingrone G et al. Acetyl-l-carnitine infusion increases glucose disposal in type 2 diabetic patients. Metabolism 2000; 49: 704-8.
11. Lee WJ, Song KH, Koh EH et al. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem. Biophys. Res. Commun. 2005; 332: 885-91.
12. Velykyi MM, Burda VA, Biront NV, Oliiarnyk OD, Velykyi AM. The effect of nicotinamide on the enzymatic activity of the antioxidant defense in experimental diabetes. Ukr. Biokhim. Zh. 1996; 68: 109-14.
13. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995; 44: 863-70.
14. Cresto JC, Fabiano de Bruno LE, Cao GF et al. The association of acetyl-l-carnitine and nicotinamide remits the experimental diabetes in mice by multiple low-dose streptozotocin. Pancreas 2006; 33: 403-11.
15. Chicco A, D'Alessandro ME, Karabatas L, Pastorale C, Basabe JC, Lombardo YB. Muscle lipid metabolism and insulin secretion are altered in insulin-resistant rats fed a high sucrose diet. J. Nutr. 2003; 133: 127-33.
16. Pighin D, Karabatas L, Rossi A, Chicco A, Basabe JC, Lombardo YB. Fish oil affects pancreatic fat storage, pyruvate dehydrogenase complex activity and insulin secretion in rats fed a sucrose-rich diet. J. Nutr. 2003; 133: 4095-101.
17. Ferreira MR, Lombardo YB, Chicco A. β-Cell adaptation/dysfunction in an animal model of dyslipidemia and insulin resistance induced by the chronic administration of a sucrose-rich diet. Islets 2010; 2: 367-73.
18. Chicco A, Basabe JC, Karabatas L, Ferraris N, Fortino A, Lombardo YB. Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats. Metabolism 2000; 49: 1346-51.
19. Davoren PR. The isolation of insulin from a single cat pancreas. Biochim. Biophys. Acta 1962; 63: 150-3.
20. Lombardo YB, Chicco A, D'Alessandro ME, Martinelli M, Soria A, Gutman R. Dietary fish oil normalize dyslipidemia and glucose intolerance with unchanged insulin levels in rats fed a high sucrose diet. Biochim. Biophys. Acta 1996; 1299: 175-82.
21. Gutman RA, Basilico MZ, Bernal C, Chicco A, Lombardo YB. Long-term hypertriglyceridemia and glucose intolerance in rats fed chronically an isocaloric sucrose-rich diet. Metabolism 1987; 36: 1013-20.
22. Zimmermann R, Haemmerle G, Wagner EM, Strauss JG, Kratky D, Zechner R. Decreased fatty acid esterification compensates for the reduced lipolytic activity in hormone-sensitive lipase-deficient white adipose tissue. J. Lipid Res. 2003; 44: 2089-99.
23. Halestrap AP, Denton RM. Insulin and the regulation of adipose tissue acetyl-coenzyme A carboxylase. Biochem. J. 1973; 132: 509-17.
24. Karlic H, Lohninger S, Koeck T, Lohninger A. Dietary l-carnitine stimulates carnitine acyltransferases in the liver of aged rats. J. Histochem. Cytochem. 2002; 50: 205-12.
25. Snedecor GWP, Cochran WG. Statistical Methods. Iowa State University Press, Ames. 1967.
26. Mingorance C, del Gonzalez PM, Dolores HM, Alvarez de SM. Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats. Br. J. Nutr. 2009; 102: 1145-53.
27. Power RA, Hulver MW, Zhang JY et al. Carnitine revisited: Potential use as adjunctive treatment in diabetes. Diabetologia 2007; 50: 824-32.
28. Shen W, Hao J, Tian C et al. A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats. PLoS ONE 2008; 3: e2328.
29. D'Alessandro ME, Chicco A, Lombardo YB. A long-term sucrose-rich diet increases diacylglycerol content and membrane nPKCθ expression and alters glucose metabolism in skeletal muscle of rats. Nutr. Res. 2006; 26: 289-96.
30. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: A reexamination. Diabetes 2000; 49: 677-83.
31. Koves TR, Li P, An J et al. Peroxisome proliferator-activated receptor-gamma co-activator 1 alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J. Biol. Chem. 2005; 280: 33588-98.
32. Zhang Z, Zhao M, Li Q, Zhao H, Wang J, Li Y. Acetyl-l-carnitine inhibits TNF-alpha-induced insulin resistance via AMPK pathway in rat skeletal muscle cells. FEBS Lett. 2009; 583: 470-4.
33. Yoshikawa Y, Ueda E, Sakurai H, Kojima Y. Anti-diabetes effect of Zn(II)/carnitine complex by oral administration. Chem. Pharm. Bull. 2003; 51: 230-1.
34. Alenzi FQ. Effect of nicotinamide on experimental induced diabetes. Iran. J. Allergy Asthma Immunol. 2009; 8: 11-18.
35. Shima K, Zhu M, Kuwajima M. A role of nicotinamide-induced increase in pancreatic beta-cell mass on blood glucose control after discontinuation of the treatment in partially pancreatectomized OLETF rats. Diabetes Res. Clin. Pract. 1998; 41: 1-8.
36. Amin KA, Nagy MA. Effect of carnitine and herbal mixture extract on obesity induced by high fat diet in rats. Diabetol. Metab. Syndr. 2009; 1: 17.